Jan 23, 2019 - Johnson & Johnson expects its sales growth to slow down this year due to pricing pressures and generic-drug competition for its pharmaceutical division. This has put healthcare ETFs in focus.
Jan 23, 2019 - Companies In The News Are:
Jan 23, 2019 - AbbVie (ABBV) is likely to beat earnings in fourth quarter. Impressive sales of its key drug, Humira and strong growth of Imbruvica and Mavyret are expected to drive fourth-quarter sales.
Jan 22, 2019 - JNJ earnings call for the period ending December 31, 2018.
Jan 22, 2019 -
Jan 22, 2019 - Ryan McQueeney recaps China's latest economic data as well as earnings results from Johnson & Johnson and Halliburton. He also highlights activist interest in EBay. Later, Ryan chats with Dave Bartosiak about today's news and the upcoming report of IBM.
Jan 22, 2019 - J&J (JNJ) beats estimates for both earnings and sales in the fourth quarter of 2018. 2019 sales view misses expectations. Shares up in pre-market trading
Jan 22, 2019 - China???s 6.6% annual growth was its lowest in nearly 30 years, and Xi has called a private meeting of party heads to discuss a way forward.
Jan 21, 2019 - AbbVie's (ABBV) Imbruvica falls short of meeting the primary endpoint of PFS or OS benefit in a phase III study that probed its combo usage in first-line metastatic pancreatic cancer.
Jan 21, 2019 - In observance of Dr. Martin Luther King, Jr's birthday, markets are closed today.